Daptomycin alleviates collagen-induced arthritis via suppressing inflammatory cytokines and NF-κB pathway
International Immunopharmacology · 2025-01 · 144 · 113648
DOI: 10.1016/j.intimp.2024.113648 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-01. Verfasst von Yang Ye und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, No…. Hauptthemen laut MEDLINE: Arthritis, Experimental, Daptomycin, Cytokines, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sichuan Provincial Science and Technology Support Program, Sichuan University, Science and Technology Department of Sichuan Province.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a chronic autoimmune disease, and its pathogenic factors include bacterial infection and immune inflammation. Daptomycin (DAP) is a cyclic lipopeptide that has been approved to treat skin infections, bacteremia and right-sided endocarditis due to its effective antibacterial effects against most Gram-positive pathogenic bacteria. Herein, we focus on whether DAP exerts anti-inflammatory activity on RA to expand DAP drug indications. Our studies are first time to evaluate anti-inflammatory effect and reveal its molecular pharmacological mechanism of DAP on lipopolysaccharide-activated macrophage and collagen-induced arthritis (CIA) mice. In vitro cytological studies show that 10 µg/mL DAP inhibits secretion of IL-1β, IL-6 and TNF-α to alleviate cell inflammation, and the phosphorylation level of p65 (p-p65) of RAW 264.7 cells is decreased under DAP exposure. Administration with 10 mg/kg/2d DAP via intravenous injection on CIA mice significantly reduces arthritis symptom by inhibiting p-p65 level and decreasing serum level of IL-6, IL-1β and TNF-α. Moreover, our study is the first time to reveal new immunomodulatory effects of DAP on RA, which provides a pharmacological basis for new clinical applications of DAP for other immune-related diseases except to bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, No.17, 3rd Section of People's South Road, Chengdu, 610041, PR China.
- Department of Rheumatology, West China Hospital, Sichuan University, Chengdu 610041, PR China.
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, No.17, 3rd Section of People's South Road, Chengdu, 610041, PR China. El…
Förderung
- Sichuan Provincial Science and Technology Support Program
- Sichuan University
- Science and Technology Department of Sichuan Province
Zitieren
APA
Ye, Y., Liang, Y., Huang, L., Cao, X., Xia, Z., & Liang, S. (2025). Daptomycin alleviates collagen-induced arthritis via suppressing inflammatory cytokines and NF-κB pathway. International Immunopharmacology, 144, 113648. https://doi.org/10.1016/j.intimp.2024.113648
Vancouver
Ye Y, Liang Y, Huang L, Cao X, Xia Z, Liang S. Daptomycin alleviates collagen-induced arthritis via suppressing inflammatory cytokines and NF-κB pathway. International Immunopharmacology. 2025;144:113648. doi:10.1016/j.intimp.2024.113648
BibTeX
@article{Ye2025,
author = {Ye, Yang and Liang, Yue and Huang, Lan and Cao, Xu and Xia, Zijing and Liang, Shufang},
title = {Daptomycin alleviates collagen-induced arthritis via suppressing inflammatory cytokines and NF-κB pathway},
journal = {International Immunopharmacology},
year = {2025},
volume = {144},
pages = {113648},
doi = {10.1016/j.intimp.2024.113648}
}
EUVIMED